The new treatment is being developed at the CEO's leadership at the Accelerated Evolution Biotechnology Pharmacy Laboratory. Ilan Morad, according to the report.
"We believe that a complete cure for cancer will be offered in one year"he said Dan Aridor, head of the company committee. "The cure for our cancer will be effective as of the first day, it will last for a few weeks and will have minimal side effects or at a much lower cost than most treatments on the market.".
The treatment, called "MuTaTo", will combine cancer cells against cancer cells and cancer cells.
The treatment will eventually be personalized and a specific drug cocktail of patients will be given according to the type of cancer, Morad said in the newspaper.
Despite the importance of the announcement, some voices question the operation of the new treatment, for example, it has only been tested in the mouse.
In this regard, the deputy director of the National Office of the American Cancer Society, Len Lichtenfeldsaid the agency's blog "To be honest, we all share that hope is correct".
"Unfortunately, we must be aware that in addition to being an effective treatment for people with cancer, they only heal"he said.
In conclusion, according to experts, Israeli researchers did not publicly announce the data they received, and evidence proved that the treatment was successful in the mice, and they all determine what they have done so far with a local media interview, according to the published site publimetro.cl.